Prion protein as a mediator of synaptic transmission

References

• Conforti L, Adalbert R, Coleman MP. Neuronal death: where does the end begin? Trends Neurosci 2007; 30:159-66; PMID:17339056; http://dx.doi.org/10.1016/j.tins.2007.02.004
   PubMed Web of Science ®Google Scholar
• Milnerwood AJ, Raymond LA. Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease. Trends Neurosci 2010; 33:513-23; PMID:20850189; http://dx.doi.org/10.1016/j.tins.2010.08.002
   PubMed Web of Science ®Google Scholar
• Picconi B, Ghiglieri V, Bagetta V, Barone I, Sgobio C, Calabresi P. Striatal synaptic changes in experimental parkinsonism: role of NMDA receptor trafficking in PSD. Parkinsonism Relat Disord 2008; 14(Suppl 2):S145-9; PMID:18583173; http://dx.doi.org/10.1016/j.parkreldis.2008.04.019
   PubMedGoogle Scholar
• Marcello E, Epis R, Saraceno C, Di Luca M. Synaptic dysfunction in Alzheimer's disease. Adv Exp Med Biol 2012; 970:573-601; PMID:22351073; http://dx.doi.org/10.1007/978-3-7091-0932-8_25
   PubMed Web of Science ®Google Scholar
• Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673-728; PMID:18391177; http://dx.doi.org/10.1152/physrev.00007.2007
   PubMed Web of Science ®Google Scholar
• Caughey B, Baron GS, Chesebro B, Jeffrey M. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Ann Rev Biochem 2009; 78:177-204; PMID:19231987; http://dx.doi.org/10.1146/annurev.biochem.78.082907.145410
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363-83; PMID:9811807; http://dx.doi.org/10.1073/pnas.95.23.13363
   PubMed Web of Science ®Google Scholar
• Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930-6; PMID:17991853; http://dx.doi.org/10.1126/science.1138718
   PubMed Web of Science ®Google Scholar
• Shorter J, Lindquist S. Prions as adaptive conduits of memory and inheritance. Nat Rev Genet 2005; 6:435-50; PMID:15931169; http://dx.doi.org/10.1038/nrg1616
   PubMed Web of Science ®Google Scholar
• Lloyd SE, Mead S, Collinge J. Genetics of prion diseases. Curr Opin Genet Dev 2013; 23:345-51; PMID:23518043; http://dx.doi.org/10.1016/j.gde.2013.02.012
   PubMed Web of Science ®Google Scholar
• Aguzzi A. Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis. J Neurochem 2006; 97:1726-39; PMID:16805779; http://dx.doi.org/10.1111/j.1471-4159.2006.03909.x
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Calella AM. Prions: protein aggregation and infectious diseases. Physiol Rev 2009; 89:1105-52; PMID:19789378; http://dx.doi.org/10.1152/physrev.00006.2009
   PubMed Web of Science ®Google Scholar
• Benvegnu S, Poggiolini I, Legname G. Neurodevelopmental expression and localization of the cellular prion protein in the central nervous system of the mouse. J Comp Neurol 2010; 518:1879-91; PMID:20394048; http://dx.doi.org/10.1002/cne.22357
   PubMed Web of Science ®Google Scholar
• Fournier JG, Escaig-Haye F, Billette de Villemeur T, Robain O, Lasmezas CI, Deslys JP, Dormont D, Brown P. Distribution and submicroscopic immunogold localization of cellular prion protein (PrPc) in extracerebral tissues. Cell Tissue Res 1998; 292:77-84; PMID:9506914; http://dx.doi.org/10.1007/s004410051036
   PubMed Web of Science ®Google Scholar
• Moya KL, Sales N, Hassig R, Creminon C, Grassi J, Di Giamberardino L. Immunolocalization of the cellular prion protein in normal brain. Microsc Res Tech 2000; 50:58-65; PMID:10871549; http://dx.doi.org/10.1002/1097-0029(20000701)50:1%3c58::AID-JEMT9%3e3.0.CO;2-5
   PubMed Web of Science ®Google Scholar
• Barmada S, Piccardo P, Yamaguchi K, Ghetti B, Harris DA. GFP-tagged prion protein is correctly localized and functionally active in the brains of transgenic mice. Neurobiol Dis 2004; 16:527-37; PMID:15262264; http://dx.doi.org/10.1016/j.nbd.2004.05.005
   PubMed Web of Science ®Google Scholar
• Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM. Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 2012; 15:1227-35; PMID:22820466; http://dx.doi.org/10.1038/nn.3178
   PubMed Web of Science ®Google Scholar
• Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H, Kerrisk ME, Vortmeyer A, Wisniewski T, Koleske AJ, et al. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein. Neuron 2013; 79:887-902; PMID:24012003; http://dx.doi.org/10.1016/j.neuron.2013.06.036
   PubMed Web of Science ®Google Scholar
• Wu G, Nakajima K, Takeyama N, Yukawa M, Taniuchi Y, Sakudo A, Onodera T. Species-specific anti-apoptotic activity of cellular prion protein in a mouse PrP-deficient neuronal cell line transfected with mouse, hamster, and bovine Prnp. Neurosci Lett 2008; 446:11-5; PMID:18809465; http://dx.doi.org/10.1016/j.neulet.2008.09.020
   PubMed Web of Science ®Google Scholar
• Carulla P, Bribian A, Rangel A, Gavin R, Ferrer I, Caelles C, Del Río JA, Llorens F. Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding. Mol Biol Cell 2011; 22:3041-54; PMID:21757544; http://dx.doi.org/10.1091/mbc.E11-04-0321
   PubMed Web of Science ®Google Scholar
• Hetz C, Maundrell K, Soto C. Is loss of function of the prion protein the cause of prion disorders? Trends Mol Med 2003; 9:237-43; PMID:12829011; http://dx.doi.org/10.1016/S1471-4914(03)00069-8
   PubMed Web of Science ®Google Scholar
• Machado CF, Beraldo FH, Santos TG, Bourgeon D, Landemberger MC, Roffe M, Martins VR. Disease-associated mutations in the prion protein impair laminin-induced process outgrowth and survival. J Biol Chem 2012; 287:43777-88; PMID:23132868; http://dx.doi.org/10.1074/jbc.M112.428235
   PubMed Web of Science ®Google Scholar
• Senatore A, Colleoni S, Verderio C, Restelli E, Morini R, Condliffe SB, Bertani I, Mantovani S, Canovi M, Micotti E, et al. Mutant PrP suppresses glutamatergic neurotransmission in cerebellar granule neurons by impairing membrane delivery of VGCC alpha(2)delta-1 Subunit. Neuron 2012; 74:300-13; PMID:22542184; http://dx.doi.org/10.1016/j.neuron.2012.02.027
   PubMed Web of Science ®Google Scholar
• Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, Jefferys JG. Prion protein is necessary for normal synaptic function. Nature 1994; 370:295-7; PMID:8035877; http://dx.doi.org/10.1038/370295a0
   PubMed Web of Science ®Google Scholar
• Maglio LE, Martins VR, Izquierdo I, Ramirez OA. Role of cellular prion protein on LTP expression in aged mice. Brain Res 2006; 1097:11-8; PMID:16730679; http://dx.doi.org/10.1016/j.brainres.2006.04.056
   PubMed Web of Science ®Google Scholar
• Rangel A, Madronal N, Gruart A, Gavin R, Llorens F, Sumoy L, Torres JM, Delgado-García JM, Del Río JA. Regulation of GABA(A) and glutamate receptor expression, synaptic facilitation and long-term potentiation in the hippocampus of prion mutant mice. PloS One 2009; 4:e7592; PMID:19855845; http://dx.doi.org/10.1371/journal.pone.0007592
   PubMed Web of Science ®Google Scholar
• Tobler I, Gaus SE, Deboer T, Achermann P, Fischer M, Rulicke T, Moser M, Oesch B, McBride PA, Manson JC. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 1996; 380:639-42; PMID:8602267; http://dx.doi.org/10.1038/380639a0
   PubMed Web of Science ®Google Scholar
• Carleton A, Tremblay P, Vincent JD, Lledo PM. Dose-dependent, prion protein (PrP)-mediated facilitation of excitatory synaptic transmission in the mouse hippocampus. Pflugers Arch 2001; 442:223-9; PMID:11417218; http://dx.doi.org/10.1007/s004240100523
   PubMed Web of Science ®Google Scholar
• Prestori F, Rossi P, Bearzatto B, Laine J, Necchi D, Diwakar S, Schiffmann SN, Axelrad H, D'Angelo E. Altered neuron excitability and synaptic plasticity in the cerebellar granular layer of juvenile prion protein knock-out mice with impaired motor control. J Neurosci 2008; 28:7091-103; PMID:18614678; http://dx.doi.org/10.1523/JNEUROSCI.0409-08.2008
   PubMed Web of Science ®Google Scholar
• Rial D, Pamplona FA, Moreira EL, Moreira KM, Hipolide D, Rodrigues DI, Dombrowski PA, Da Cunha C, Agostinho P, Takahashi RN, et al. Cellular prion protein is present in dopaminergic neurons and modulates the dopaminergic system. Eur J Neurosci 2014; 40:2479-86; PMID:24766164; http://dx.doi.org/10.1111/ejn.12600
   PubMed Web of Science ®Google Scholar
• Martins VR, Beraldo FH, Hajj GN, Lopes MH, Lee KS, Prado MA, Linden R. Prion protein: orchestrating neurotrophic activities. Curr Issues Mol Biol 2010; 12:63-86; PMID:19767651
   PubMed Web of Science ®Google Scholar
• Maglio LE, Perez MF, Martins VR, Brentani RR, Ramirez OA. Hippocampal synaptic plasticity in mice devoid of cellular prion protein. Brain Res Mol Brain Res 2004; 131:58-64; PMID:15530652; http://dx.doi.org/10.1016/j.molbrainres.2004.08.004
   PubMedGoogle Scholar
• Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, Chen L, Villemaire M, Ali Z, Jirik FR, et al. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol 2008; 181:551-65; PMID:18443219; http://dx.doi.org/10.1083/jcb.200711002
   PubMed Web of Science ®Google Scholar
• Rangel A, Burgaya F, Gavin R, Soriano E, Aguzzi A, Del Rio JA. Enhanced susceptibility of Prnp-deficient mice to kainate-induced seizures, neuronal apoptosis, and death: Role of AMPA/kainate receptors. J Neurosci Res 2007; 85:2741-55; PMID:17304577; http://dx.doi.org/10.1002/jnr.21215
   PubMed Web of Science ®Google Scholar
• Spudich A, Frigg R, Kilic E, Kilic U, Oesch B, Raeber A, Bassetti CL, Hermann DM. Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1/-2 and STAT-1. Neurobiol Dis 2005; 20:442-9; PMID:15893468; http://dx.doi.org/10.1016/j.nbd.2005.04.002
   PubMed Web of Science ®Google Scholar
• You H, Tsutsui S, Hameed S, Kannanayakal TJ, Chen L, Xia P, Engbers JD, Lipton SA, Stys PK, Zamponi GW. Abeta neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A 2012; 109:1737-42; PMID:22307640; http://dx.doi.org/10.1073/pnas.1110789109
   PubMed Web of Science ®Google Scholar
• Steinert JR, Chernova T, Forsythe ID. Nitric oxide signaling in brain function, dysfunction, and dementia. Neuroscientist 2010; 16:435-52; PMID:20817920; http://dx.doi.org/10.1177/1073858410366481
   PubMed Web of Science ®Google Scholar
• Gama Sosa MA, De Gasperi R, Elder GA. Modeling human neurodegenerative diseases in transgenic systems. Hum Genet 2012; 131:535-63; PMID:22167414; http://dx.doi.org/10.1007/s00439-011-1119-1
   PubMed Web of Science ®Google Scholar
• Park Y, Kim W, Kim AY, Choi HJ, Choi JK, Park N, Koh EK, Seo J, Koh YH. Normal prion protein in Drosophila enhances the toxicity of pathogenic polyglutamine proteins and alters susceptibility to oxidative and autophagy signaling modulators. Biochem Biophys Res Commun 2011; 404:638-45; PMID:21146501; http://dx.doi.org/10.1016/j.bbrc.2010.12.030
   PubMed Web of Science ®Google Scholar
• Gavin BA, Dolph MJ, Deleault NR, Geoghegan JC, Khurana V, Feany MB, Dolph PJ, Supattapone S. Accelerated accumulation of misfolded prion protein and spongiform degeneration in a Drosophila model of Gerstmann-Straussler-Scheinker syndrome. J Neurosci 2006; 26:12408-14; PMID:17135402; http://dx.doi.org/10.1523/JNEUROSCI.3372-06.2006
   PubMed Web of Science ®Google Scholar
• Fernandez-Funez P, Zhang Y, Casas-Tinto S, Xiao X, Zou WQ, Rincon-Limas DE. Sequence-dependent prion protein misfolding and neurotoxicity. J Biol Chem 2010; 285:36897-908; PMID:20817727; http://dx.doi.org/10.1074/jbc.M110.174391
   PubMed Web of Science ®Google Scholar
• Rincon-Limas DE, Casas-Tinto S, Fernandez-Funez P. Exploring prion protein biology in flies: genetics and beyond. Prion 2010; 4:1-8; PMID:20083902; http://dx.doi.org/10.4161/pri.4.1.10504
   PubMed Web of Science ®Google Scholar
• Thackray AM, Muhammad F, Zhang C, Di Y, Jahn TR, Landgraf M, Crowther DC, Evers JF, Bujdoso R. Ovine PrP transgenic Drosophila show reduced locomotor activity and decreased survival. Biochem J 2012; 444:487-95; PMID:22435640; http://dx.doi.org/10.1042/BJ20112141
   PubMed Web of Science ®Google Scholar
• Sanchez-Garcia J, Arbelaez D, Jensen K, Rincon-Limas DE, Fernandez-Funez P. Polar substitutions in helix 3 of the prion protein produce transmembrane isoforms that disturb vesicle trafficking. Hum Mol Genet 2013; 22:4253-66; PMID:23771030; http://dx.doi.org/10.1093/hmg/ddt276
   PubMed Web of Science ®Google Scholar
• Murali A, Maue RA, Dolph PJ. Reversible symptoms and clearance of mutant prion protein in an inducible model of a genetic prion disease in Drosophila melanogaster. Neurobiol Dis 2014; 67:71-8; PMID:24686303; http://dx.doi.org/10.1016/j.nbd.2014.03.013
   PubMed Web of Science ®Google Scholar
• Robinson SW, Nugent ML, Dinsdale D, Steinert JR. Prion protein facilitates synaptic vesicle release by enhancing release probability. Hum Mol Genet 2014; 23:4581-96; PMID:24722203; http://dx.doi.org/10.1093/hmg/ddu171
   PubMed Web of Science ®Google Scholar
• Re L, Rossini F, Re F, Bordicchia M, Mercanti A, Fernandez OS, Barocci S. Prion protein potentiates acetylcholine release at the neuromuscular junction. Pharmacol Res 2006; 53:62-8; PMID:16256362; http://dx.doi.org/10.1016/j.phrs.2005.09.002
   PubMed Web of Science ®Google Scholar
• Fournier JG, Escaig-Haye F, Grigoriev V. Ultrastructural localization of prion proteins: physiological and pathological implications. Microsc Res Tech 2000; 50:76-88; PMID:10871551; http://dx.doi.org/10.1002/1097-0029(20000701)50:1%3c76::AID-JEMT11%3e3.0.CO;2-
   PubMed Web of Science ®Google Scholar
• Spielhaupter C, Schatzl HM. PrPC directly interacts with proteins involved in signaling pathways. J Biol Chem 2001; 276:44604-12; PMID:11571277; http://dx.doi.org/10.1074/jbc.M103289200
   PubMed Web of Science ®Google Scholar
• Shyng SL, Heuser JE, Harris DA. A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. J Cell Biol 1994; 125:1239-50; PMID:7911471; http://dx.doi.org/10.1083/jcb.125.6.1239
   PubMed Web of Science ®Google Scholar
• Magalhaes AC, Silva JA, Lee KS, Martins VR, Prado VF, Ferguson SS, Gomez MV, Brentani RR, Prado MA. Endocytic intermediates involved with the intracellular trafficking of a fluorescent cellular prion protein. J Biol Chem 2002; 277:33311-8; PMID:12070160; http://dx.doi.org/10.1074/jbc.M203661200
   PubMed Web of Science ®Google Scholar
• Hernandez-Rapp J, Martin-Lanneree S, Hirsch TZ, Pradines E, Alleaume-Butaux A, Schneider B, Baudry A, Launay JM, Mouillet-Richard S. A PrP(C)-caveolin-Lyn complex negatively controls neuronal GSK3beta and serotonin 1B receptor. Scient Rep 2014; 4:4881; PMID:24810941; http://dx.doi.org/10.1038/srep04881
   PubMed Web of Science ®Google Scholar
• Beraldo FH, Arantes CP, Santos TG, Machado CF, Roffe M, Hajj GN, Lee KS, Magalhães AC, Caetano FA, Mancini GL, et al. Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin gamma1 chain. FASEB J 2011; 25:265-79; PMID:20876210; http://dx.doi.org/10.1096/fj.10-161653
   PubMed Web of Science ®Google Scholar
• Black SA, Stys PK, Zamponi GW, Tsutsui S. Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity. Front Cell Dev Biol 2014; 2:45; PMID:25364752; http://dx.doi.org/10.3389/fcell.2014.00045
   PubMedGoogle Scholar
• Beraldo FH, Arantes CP, Santos TG, Queiroz NG, Young K, Rylett RJ, Markus RP, Prado MA, Martins VR. Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1. J Biol Chem 2010; 285:36542-50; PMID:20837487; http://dx.doi.org/10.1074/jbc.M110.157263
   PubMed Web of Science ®Google Scholar